Literature DB >> 8008205

Cholinergic mechanisms in canine narcolepsy--I. Modulation of cataplexy via local drug administration into the pontine reticular formation.

M S Reid1, M Tafti, J N Geary, S Nishino, J M Siegel, W C Dement, E Mignot.   

Abstract

Cataplexy in the narcoleptic canine has been shown to increase after systemic administration of cholinergic agonists. Furthermore, the number of cholinergic receptors in the pontine reticular formation of narcoleptic canines is significantly elevated. In the present study we have investigated the effects of cholinergic drugs administered directly into the pontine reticular formation on cataplexy, as defined by brief episodes of hypotonia induced by emotions, in narcoleptic canines. Carbachol and atropine were perfused through microdialysis probes implanted bilaterally in the pontine reticular formation of freely moving, narcoleptic and control Doberman pinschers. Cataplexy was quantified using the Food-Elicited Cataplexy Test, and analysed using recordings of electroencephalogram, electrooculogram and electromyogram. Cataplexy was characterized by a desynchronized electroencephalogram and a drop in electromyogram and electrooculogram activity. In narcoleptic canines, both unilateral and bilateral carbachol (10(-5) to 10(-3) M) produced a dose-dependent increase in cataplexy, which resulted in complete muscle tone suppression at the highest concentration. In control canines, neither bilateral nor unilateral carbachol (10(-5) to 10(-3) M) produced cataplexy, although bilateral carbachol, did produce muscle atonia at the highest dose (10(-3)). The increase in cataplexy after bilateral carbachol (10(-4) M) was rapidly reversed when the perfusion medium was switched to one containing atropine (10(-4) M). Bilateral atropine (10(-3) to 10(-2) M) alone did not produce any significant effects on cataplexy in narcoleptic canines; however, bilateral atropine (10(-2) M) did reduce the increase in cataplexy produced by systemic administration of physostigmine (0.05 mg/kg, i.v.). These findings demonstrate that cataplexy in narcoleptic canines can be stimulated by applying cholinergic agonists directly into the pontine reticular formation. The ability of atropine to inhibit locally and systemically stimulated cataplexy indicates that the pontine reticular formation is a critical component in cholinergic stimulation of cataplexy. Therefore, it is suggested that the pontine reticular formation plays a significant role in the cholinergic regulation of narcolepsy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8008205      PMCID: PMC9054050          DOI: 10.1016/0306-4522(94)90173-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.708


  50 in total

1.  Striatal dopamine and glutamate release: effects of intranigral injections of substance P.

Authors:  M S Reid; M Herrera-Marschitz; J Kehr; U Ungerstedt
Journal:  Acta Physiol Scand       Date:  1990-12

2.  Single cholinergic mesopontine tegmental neurons project to both the pontine reticular formation and the thalamus in the rat.

Authors:  K Semba; P B Reiner; H C Fibiger
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

3.  Intracerebral microdialysis: I. Experimental studies of diffusion kinetics.

Authors:  N Lindefors; G Amberg; U Ungerstedt
Journal:  J Pharmacol Methods       Date:  1989-11

4.  Intracerebral microdialysis: II. Mathematical studies of diffusion kinetics.

Authors:  G Amberg; N Lindefors
Journal:  J Pharmacol Methods       Date:  1989-11

5.  Cholinergic mechanisms and cataplexy in dogs.

Authors:  J B Delashaw; A S Foutz; C Guilleminault; W C Dement
Journal:  Exp Neurol       Date:  1979-12       Impact factor: 5.330

6.  Prazosin contraindicated in patients with narcolepsy.

Authors:  C Guilleminault; E Mignot; M Aldrich; M A Quera-Salva; M Tiberge; M Partinen
Journal:  Lancet       Date:  1988-08-27       Impact factor: 79.321

7.  Cholinergic activation of medial pontine reticular formation neurons in vitro.

Authors:  R W Greene; U Gerber; R W McCarley
Journal:  Brain Res       Date:  1989-01-02       Impact factor: 3.252

8.  Microdialysis of norepinephrine into preoptic area of guinea pigs: characteristics of hypothermic effect.

Authors:  N Quan; L Xin; C M Blatteis
Journal:  Am J Physiol       Date:  1991-08

9.  Acetylcholine hyperpolarizes central neurones by acting on an M2 muscarinic receptor.

Authors:  T M Egan; R A North
Journal:  Nature       Date:  1986 Jan 30-Feb 5       Impact factor: 49.962

10.  Sleep fragmentation in canine narcolepsy.

Authors:  K I Kaitin; T S Kilduff; W C Dement
Journal:  Sleep       Date:  1986       Impact factor: 5.849

View more
  22 in total

Review 1.  [The neurophysiology of cataplexy].

Authors:  G Mayer
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

3.  Narcoleptic orexin receptor knockout mice express enhanced cholinergic properties in laterodorsal tegmental neurons.

Authors:  M Kalogiannis; S L Grupke; P E Potter; J G Edwards; R M Chemelli; Y Y Kisanuki; M Yanagisawa; C S Leonard
Journal:  Eur J Neurosci       Date:  2010-06-22       Impact factor: 3.386

4.  Major histocompatibility class II molecules in the CNS: increased microglial expression at the onset of narcolepsy in canine model.

Authors:  M Tafti; S Nishino; M S Aldrich; W Liao; W C Dement; E Mignot
Journal:  J Neurosci       Date:  1996-08-01       Impact factor: 6.167

5.  Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy.

Authors:  S Nishino; J Arrigoni; J Shelton; T Kanbayashi; W C Dement; E Mignot
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

Review 6.  Clinical and neurobiological aspects of narcolepsy.

Authors:  Seiji Nishino
Journal:  Sleep Med       Date:  2007-04-30       Impact factor: 3.492

Review 7.  Animal models of sleep disorders.

Authors:  Linda A Toth; Pavan Bhargava
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

8.  A consensus definition of cataplexy in mouse models of narcolepsy.

Authors:  Thomas E Scammell; Jon T Willie; Christian Guilleminault; Jerome M Siegel
Journal:  Sleep       Date:  2009-01       Impact factor: 5.849

9.  Role of the medial prefrontal cortex in cataplexy.

Authors:  Yo Oishi; Rhiannan H Williams; Lindsay Agostinelli; Elda Arrigoni; Patrick M Fuller; Takatoshi Mochizuki; Clifford B Saper; Thomas E Scammell
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

10.  Animal models of narcolepsy.

Authors:  Lichao Chen; Ritchie E Brown; James T McKenna; Robert W McCarley
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-08       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.